|
|
 |
|
Viewing report
|
|
|
|
India: Pharmaceuticals 2H10
Emerging Markets Direct, Oct 2010, Pages: 27
India: Pharmaceuticals 2H10 includes an overview of India’s pharmaceutical industry, where the first part of this report explains India’s domestic pharmaceutical industry, pharmaceutical imports and exports as well as Central Pharma Public Sector Undertakings (PSUs). The US remains the top export destination for Indian pharmaceutical products, in which export value jumped 21.64% during 2008-09.
The second part of this report includes current trends and issues in India’s pharmaceutical industry, comprising government schemes, the country’s generics production, R&D initiatives, India’s Vision 2015 as well as other initiatives undertaken by the Indian government to boost this industry.
A ranking of the major companies in this industry are included in the final part of this report, where current leading players include Ranbaxy, Dr Reddy’s, Cipla and Lupin. This part also includes a comparative matrix of the financial highlights as well as SWOT analysis of these companies.
Customers who bought this item also bought
Booming Generics Drug Market in India
Indian Pharmaceutical Industry: Issues and Opportunities
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
Indian Pharmaceutical Industry, Q4 2011
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
Global Biopharma Outlook 2011: India Pharma
Prescription Drugs - Global Strategic Business Report
The Pharmaceutical Market: India
Indian Bulk Drug Market - Industry Insight
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
|
|
|
|
